Biotech Momentum Lost Mired in Macro-Economic News Cycle: China, FED,Trade etc.
Biotech Momentum Lost Technical Breakdown: XBI Near April Bottom but XLV Looks Good Market Looking for Growth from Large Cap Earnings 10 year auction has tepid demand at Yield of 3.225%, NASDAQ at 7602 own 1.75% (Prices as of mid-day 1:30 p EDT) Biotech momentum losses were triggered by a...
Rayno BioBeat #6: Biotech Sell-Off with Broad Market Concerns…Updates
Update 10/5/18 Very Weak Technicals after Biotech Sell-Off NASDAQ market closed off the lows down 1.16% at 7788. Biotech ETF IBB down 1.15% just above 3 month support of 116. Biotech ETF XBI down 1.51% at 90.45 broke downtrend line and May support at 92. More losers again but a several winners:...
Mid-Cap Biopharma 2018 Stock Performance as of 9/30…Updates
Update-10/1 Rally Fades Early Today...NASDAQ Moves to Red An early rally faded quickly today after an initial spike from new "NAFTA" deal. Biotech ETFs were red IBB down 0.63% and XBI down 1.34%. Mid-Cap biopharmas were mainly red with CAR-T and gene editing stocks hit hard: BLUE CRSP EDIT...
Biotech Bounces to Trend Line-Clinical News Lifts Stocks…Update ALXN, TSRO
Update 9/26: FED Rate Hike Curbs Traders but Biotech Rolls On The market dipped slightly then went red about 3:30P EDT resulting in a 0.4% loss for the Dow. Main rates will rise to the 2 to 2.25% level with more rate hikes in the future. During Trump's Press Conference today he said he does not...
Biotechs Bounce Back, Dow and S&P Hit New Highs
Biotechs Bounce Back: Up From September Lows-Markets Surge Ahead XBI Up 1.66% to $97.16 up from 3 month tech support of $95;IBB up 1.39%. Broad rally brings Dow up 1%, S&P up 0.81% to fresh highs-strong 4 mo. trend line. Sector Winners: Tech (XLK) up 1.18%, Materials (XLB) up 1.08%, Healthcare...